Tominersen 60 mg ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

8. ハンチントン病

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05686551 (ClinicalTrials.gov)	January 30, 2023	16/12/2022	GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With ...	A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, ...	Huntington Disease	Drug: Tominersen 60 mg;Drug: Placebo;Drug: Tominersen 100 mg	Hoffmann-La Roche	NULL	Recruiting	25 Years	50 Years	All	360	Phase 2	United States;Spain

First Previous1Next Last